Revenues drop in 1998 at Norland

Article

Bone densitometry firm Norland Medical Systems of White Plains, NY, published its 1998 financial results this month, posting revenue for the fourth quarter (end-December) of $3.3 million, compared with $5.7 million in 1997. The net loss for the

Bone densitometry firm Norland Medical Systems of White Plains, NY, published its 1998 financial results this month, posting revenue for the fourth quarter (end-December) of $3.3 million, compared with $5.7 million in 1997. The net loss for the quarter was $4.3 million, compared with $2.8 million the previous year. The company’s fiscal 1998 revenues fell to $14.4 million, down from 1997’s $20.5 million. The net loss for the year was $9.7 million, compared with $18.6 million the year before.

The company attributed its decreased revenues to debt and unresolved litigation related to the acquisition of its manufacturing partner, Norland Corp. The distractions affected the company’s sales efforts, according to Reynald Bonmati, chair and CEO. But on Dec. 31, the firm signed an agreement to settle the lawsuit, a move that contributed to the reduction of the company’s debt by about 66%.

In other news, Norland also this month began shipping Excell DXA, an axial scanner that is the first table scanner in the U.S. listed below $30,000. The company introduced the unit at last year’s Radiological Society of North America meeting.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.